The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Downregulated MicroRNA-200a in Meningiomas Promotes Tumor Growth by Reducing E-Cadherin and Activating the Wnt/β-Catenin Signaling Pathway
Open accessAbstract
Meningiomas, one of the most common human brain tumors, are derived from arachnoidal cells associated with brain meninges, are usually benign, and are frequently associated with neurofibromatosis type 2. Here, we define a typical human meningioma microRNA (miRNA) profile and characterize the effects of one downregulated miRNA, miR-200a, on tumor growth. Elevated levels of miR-200a inhibited meningioma cell growth in culture and in a tumor model in vivo. Upregulation of miR-200a decreased the expression of transcription factors ZEB1 and SIP1, with consequent increased expression of E-cadherin, an adhesion protein associated with cell differentiation. Downregulation of miR-200a in meningiomas and arachnoidal cells resulted in increased expression of beta-catenin and cyclin D1 involved in cell proliferation. miR-200a was found to directly target beta-catenin mRNA, thereby inhibiting its translation and blocking Wnt/beta-catenin signaling, which is frequently involved in cancer. A direct correlation was found between the downregulation of miR-200a and the upregulation of beta-catenin in human meningioma samples. Thus, miR-200a appears to act as a multifunctional tumor suppressor miRNA in meningiomas through effects on the E-cadherin and Wnt/beta-catenin signaling pathways. This reveals a previously unrecognized signaling cascade involved in meningioma tumor development and highlights a novel molecular interaction between miR-200a and Wnt signaling, thereby providing insights into novel therapies for meningiomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
A microRNA expression signature of human solid tumors defines cancer gene targets
Volinia, S., Calin, G. A., Liu, C.-G., Ambs, S., Cimmino, A., Petrocca, F., Visone, R., Iorio, M., Roldo, C., Ferracin, M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510565103 · Cited by 5,697
Calin, G. A., Dumitru, C. D., Shimizu, M., Bichi, R., Zupo, S., Noch, E., Aldler, H., Rattan, S., Keating, M., Rai, K., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242606799 · Cited by 5,111
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew-Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,863
miR-15 and miR-16 induce apoptosis by targeting BCL2
Cimmino, A., Calin, G. A., Fabbri, M., Iorio, M. V., Ferracin, M., Shimizu, M., Wojcik, S. E., Aqeilan, R. I., Zupo, S., Dono, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506654102 · Cited by 3,517
Non-coding RNAs and cancer: microRNAs and beyond
Raia, R. M., & Calin, G. A. (2011) · Journal of Nucleic Acids Investigation · doi:10.4081/jnai.2011.e5 · Cited by 3,382
Polakis, P. (2000) · Genes & Development · doi:10.1101/gad.14.15.1837 · Cited by 3,183
Processing of primary microRNAs by the Microprocessor complex
Denli, A. M., Tops, B. B. J., Plasterk, R. H. A., Ketting, R. F., & Hannon, G. J. (2004) · Nature · doi:10.1038/nature03049 · Cited by 2,784
MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer
Meng, F., Henson, R., Wehbe–Janek, H., Ghoshal, K., Jacob, S. T., & Patel, T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.022 · Cited by 2,773
Tumour invasion and metastasis initiated by microRNA-10b in breast cancer
Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06174 · Cited by 2,605
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
Self-citationPark, S.-M., Gaur, A. B., Lengyel, E., & Peter, M. E. (2008) · Genes & Development · doi:10.1101/gad.1640608 · Cited by 2,272 · cited 15×
“Recent studies showed that the members of the miR-200 family, including miR-200a, inhibit EMT as the initial step in tumorigenesis by directly targeting mRNAs for the transcriptional repressors ZEB1 and SIP1 (4, 12, 20, 32).”
BackgroundInfluentialWNT and β-catenin signalling: diseases and therapies
Moon, R. T., Kohn, A. D., Ferrari, G. V. D., & Kaykas, A. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1427 · Cited by 1,763
Burk, U., Schubert, J., Wellner, U., Schmalhofer, O., Vincan, E., Spaderna, S., & Brabletz, T. (2008) · EMBO reports · doi:10.1038/embor.2008.74 · Cited by 1,722
Korpal, M., Lee, E. S., Hu, G., & Kang, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.c800074200 · Cited by 1,645
The New WHO Classification of Brain Tumours
Kleihues, P., Burger, P. C., & Scheithauer, B. W. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00752.x · Cited by 1,587
Rouleau, G. A., Merel, P., Lutchman, M., Sanson, M., Zucman, J., Marineau, C., Hoang-Xuan, K., Demczuk, S., Desmaze, C., Plougastel, B., et al. (1993) · Nature · doi:10.1038/363515a0 · Cited by 1,420
Trofatter, J. (1993) · Cell · doi:10.1016/0092-8674(93)90406-g · Cited by 1,403
Wnt Signaling in Oncogenesis and Embryogenesis--a Look Outside the Nucleus
Peifer, M., & Polakis, P. (2000) · Science · doi:10.1126/science.287.5458.1606 · Cited by 1,253
(2005) · doi:10.1093/nar/gki200 · Cited by 1,208
A microRNA array reveals extensive regulation of microRNAs during brain development
KRICHEVSKY, A. M., KING, K. S., DONAHUE, C. P., KHRAPKO, K., & KOSIK, K. S. (2003) · RNA · doi:10.1261/rna.5980303 · Cited by 1,040
Self-citationThe Promise and Perils of Wnt Signaling Through β-Catenin
Moon, R. T., Bowerman, B., Boutros, M., & Perrimon, N. (2002) · Science · doi:10.1126/science.1071549 · Cited by 969
Cadherins and cancer: how does cadherin dysfunction promote tumor progression?
Jeanes, A., Gottardi, C. J., & Yap, A. S. (2008) · Oncogene · doi:10.1038/onc.2008.343 · Cited by 772
Codon-Optimized Gaussia Luciferase cDNA for Mammalian Gene Expression in Culture and in Vivo
Tannous, B. A., Kim, D.-E., Fernandez, J. L., Weissleder, R., & Breakefield, X. O. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.10.016 · Cited by 682
Self-citationRegulation of the Adenomatous Polyposis Coli Gene by the miR-135 Family in Colorectal Cancer
Nagel, R., le Sage, C., Diosdado, B., van der Waal, M., Oude Vrielink, J. A. F., Bolijn, A., Meijer, G. A., & Agami, R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0951 · Cited by 474
Wnt/β-catenin signaling: new (and old) players and new insights
Huang, H., & He, X. (2008) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2008.01.009 · Cited by 419
Weber, R. G., Boström, J., Wolter, M., Baudis, M., Collins, V. P., Reifenberger, G., & Lichter, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14719 · Cited by 407
miTarget: microRNA target gene prediction using a support vector machine
Kim, S.-K., Nam, J.-W., Rhee, J.-K., Lee, W.-J., & Zhang, B.-T. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-411 · Cited by 228
Simon, M., von Deimling, A., Larson, J. M., Wellenreuther, R., Kaskel, P., Waha, A., Warnick, R. E., Tew, J. M., & Menon, A. G. (1995) · PubMed · Cited by 211
WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data
Yi, M., Horton, J. D., Cohen, J. C., Hobbs, H. H., & Stephens, R. M. (2006) · BMC Bioinformatics · doi:10.1186/1471-2105-7-30 · Cited by 210
Self-citationNF2 gene mutations and allelic status of 1p, 14q and 22q in sporadic meningiomas
Leone, P., Bello, M. J., de Campos, J. M., Vaquero, J., Sarasa, J. L., Pestaña, Á., & REY, J. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202531 · Cited by 146
A Highly Sensitive Assay for Monitoring the Secretory Pathway and ER Stress
Badr, C. E., Hewett, J. W., Breakefield, X. O., & Tannous, B. A. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000571 · Cited by 142
Self-citationMeningioma Transcript Profiles Reveal Deregulated Notch Signaling Pathway
Cuevas, I., Slocum, A. L., Jun, P., Costello, J., Bollen, A. W., Riggins, G. J., McDermott, M. W., & Lal, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0240 · Cited by 112
Huang, D., & Du, X. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.1823 · Cited by 103
c-Myc: Linking Transformation and Genomic Instability
Prochownik, E. V. (2008) · Current Molecular Medicine · doi:10.2174/156652408785747988 · Cited by 101
BCR-ABL-transformed GMP as myeloid leukemic stem cells
Minami, Y., Stuart, S. A., Ikawa, T., Jiang, Y. D., Banno, A., Hunton, I. C., Young, D. J., Naoe, T., Murre, C., Jamieson, C. H. M., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808303105 · Cited by 93
Joachim, T., Ram, Z., Rappaport, Z. H., Simon, M., Schramm, J., Wiestler, O. D., & von Deimling, A. (2001) · International Journal of Cancer · doi:10.1002/ijc.1467 · Cited by 93
Saydam, O., Glauser, D. L., Heid, I., Türkeri, G., Hilbe, M., Jacobs, A. H., Ackermann, M., & Fraefel, C. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.07.534 · Cited by 74
Self-citationTohma, Y., Yamashima, T., & Yamashita, J. (1992) · PubMed · Cited by 70
Shen, Y., Miller, D. T., Cheung, S. W., Lip, V., Sheng, X., Tomaszewicz, K., Shao, H., Fang, H., Tang, H. S., Irons, M., et al. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.090290 · Cited by 64
Self-citationJames, M. F., Lelke, J. M., MacCollin, M., Plotkin, S. R., Stemmer-Rachamimov, A. O., Ramesh, V., & Gusella, J. F. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.09.002 · Cited by 49
Self-citationProgress toward the Isolation and Characterization of the Genes Causing Neurofibromatosis
Menon, A. G., Gusella, J. F., & Seizinger, B. R. (1990) · Brain Pathology · doi:10.1111/j.1750-3639.1990.tb00636.x · Cited by 14
Self-citation
Cited by
Vallée, A., & Lecarpentier, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00745 · Cited by 374
Tumor Immune Microenvironment during Epithelial–Mesenchymal Transition
Taki, M., Abiko, K., Ukita, M., Murakami, R., Yamanoi, K., Yamaguchi, K., Hamanishi, J., Baba, T., Matsumura, N., & Mandai, M. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4459 · Cited by 351
EMT Factors and Metabolic Pathways in Cancer
Georgakopoulos-Soares, I., Chartoumpekis, D. V., Kyriazopoulou, V., & Zaravinos, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00499 · Cited by 349
Humphries, B., & Yang, C. (2015) · Oncotarget · doi:10.18632/oncotarget.3052 · Cited by 346
Genetically Engineered Microvesicles Carrying Suicide mRNA/Protein Inhibit Schwannoma Tumor Growth
Mizrak, A., Bolukbasi, M. F., Ozdener, G. B., Brenner, G. J., Madlener, S., Erkan, E. P., Ströbel, T., Breakefield, X. O., & Saydam, O. (2013) · Molecular Therapy · doi:10.1038/mt.2012.161 · Cited by 337
Self-citation
Metadata
- Authors
- Saydam, O., Shen, Y., Würdinger, T., Senol, O., Boke, E., James, M. F., Tannous, B. A., Stemmer-Rachamimov, A. O., Yi, M., Stephens, R. M., Fraefel, C., Gusella, J. F., Krichevsky, A. M., & Breakefield, X. O.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2009-11-01
- Volume
- 29
- Issue
- 21
- Pages
- 5923-5940
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2117139716
- Cited by
- 255
- References
- 44
- FWCI
- 6.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.